154 related articles for article (PubMed ID: 33481245)
1. Poor mobilization of autologous CD34
Gifford G; Hesson L; Wong JWH; Carroll A; Gabrielli S; Bai L; Xia W; Stevenson W; Greenwood M
Br J Haematol; 2021 May; 193(4):841-844. PubMed ID: 33481245
[TBL] [Abstract][Full Text] [Related]
2. Poor peripheral blood stem cell mobilization affects long-term outcomes in multiple myeloma patients undergoing autologous stem cell transplantation.
Moreb JS; Byrne M; Shugarman I; Zou F; Xiong S; May WS; Norkin M; Hiemenz J; Brown R; Cogle C; Wingard JR; Hsu JW
J Clin Apher; 2018 Feb; 33(1):29-37. PubMed ID: 28556233
[TBL] [Abstract][Full Text] [Related]
3. An antecedent diagnosis of refractory anemia with excess blasts has no influence on mobilization of peripheral blood stem cells and hematopoietic recovery after autologous stem cell transplantation in acute myeloid leukemia.
Viola A; Falco C; D'Elia R; D'Amico MR; Vicari L; Tambaro FP; Correale P; Laudati D; Palmieri S; Ferrara F
Eur J Haematol; 2007 Jan; 78(1):41-7. PubMed ID: 17042770
[TBL] [Abstract][Full Text] [Related]
4. Incidence and risk factors of poor mobilization in adult autologous peripheral blood stem cell transplantation: a single-centre experience.
Lee KH; Jung SK; Kim SJ; Jang JH; Kim K; Kim WS; Jung CW; Kim DW; Kang ES
Vox Sang; 2014 Nov; 107(4):407-15. PubMed ID: 25130876
[TBL] [Abstract][Full Text] [Related]
5. Increased plasma EPO and MIP-1 alpha are associated with recruitment of vascular progenitors but not CD34(+) cells in autologous peripheral blood stem cell grafts.
Labonté L; Li Y; Yang L; Gillingham A; Halpenny M; Giulivi A; Sills T; Evans K; Zanke B; Allan DS
Exp Hematol; 2009 Jun; 37(6):673-8. PubMed ID: 19463769
[TBL] [Abstract][Full Text] [Related]
6. Adverse Prognostic Factors for Morbidity and Mortality During Peripheral Blood Stem Cell Mobilization in Patients with Light Chain Amyloidosis.
Yeh JC; Shank BR; Milton DR; Qazilbash MH
Biol Blood Marrow Transplant; 2018 Apr; 24(4):815-819. PubMed ID: 29223373
[TBL] [Abstract][Full Text] [Related]
7. Poor mobilization of peripheral blood stem cells is a risk factor for worse outcome in lymphoma patients undergoing autologous stem cell transplantation.
Gordan LN; Sugrue MW; Lynch JW; Williams KD; Khan SA; Wingard JR; Moreb JS
Leuk Lymphoma; 2003 May; 44(5):815-20. PubMed ID: 12802919
[TBL] [Abstract][Full Text] [Related]
8. Third time's a charm? Mobilization of autologous peripheral blood stem cells in patients with two previous failed mobilizations with plerixafor.
Zhuang L; Boriboonnangkul P; Wang S; Yuan S
Transfusion; 2020 Jun; 60(6):1253-1259. PubMed ID: 32483875
[TBL] [Abstract][Full Text] [Related]
9. Reduced dose of lenograstim is as efficacious as standard dose of filgrastim for peripheral blood stem cell mobilization and transplantation: a randomized study in patients undergoing autologous peripheral stem cell transplantation.
Ataergin S; Arpaci F; Turan M; Solchaga L; Cetin T; Ozturk M; Ozet A; Komurcu S; Ozturk B
Am J Hematol; 2008 Aug; 83(8):644-8. PubMed ID: 18508321
[TBL] [Abstract][Full Text] [Related]
10. Management strategies for poor peripheral blood stem cell mobilization.
Moog R
Transfus Apher Sci; 2008 Jun; 38(3):229-36. PubMed ID: 18485822
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness analysis of a risk-adapted algorithm of plerixafor use for autologous peripheral blood stem cell mobilization.
Micallef IN; Sinha S; Gastineau DA; Wolf R; Inwards DJ; Gertz MA; Hayman SR; Hogan WJ; Johnston PB; Lacy MQ; Ansell SM; Buadi F; Dingli D; Dispenzieri A; Litzow MR; Porrata LF; Winters JL; Kumar S
Biol Blood Marrow Transplant; 2013 Jan; 19(1):87-93. PubMed ID: 22922211
[TBL] [Abstract][Full Text] [Related]
12. Endothelial-like vascular progenitor cells (VPCs) from allogeneic and autologous donors: mobilization features distinct from hematopoietic progenitors.
Allan DS; Dubé P; Roy J; Busque L; Roy DC
Biol Blood Marrow Transplant; 2007 Apr; 13(4):433-9. PubMed ID: 17382249
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Hematopoietic Stem Cell Mobilization Rates with Early Plerixafor Administration for Adult Stem Cell Transplantation.
Stover JT; Shaw JR; Kuchibhatla M; Horwitz ME; Engemann AM
Biol Blood Marrow Transplant; 2017 Aug; 23(8):1290-1294. PubMed ID: 28411174
[TBL] [Abstract][Full Text] [Related]
14. Plasma levels of FL and SDF-1 and expression of FLT-3 and CXCR4 on CD34+ cells assessed pre and post hematopoietic stem cell mobilization in patients with hematologic malignancies and in healthy donors.
Cecyn KZ; Schimieguel DM; Kimura EY; Yamamoto M; Oliveira JS
Transfus Apher Sci; 2009 Jun; 40(3):159-67. PubMed ID: 19380254
[TBL] [Abstract][Full Text] [Related]
15. PBSC mobilization in lymphoma patients: analysis of risk factors for collection failure and development of a predictive score based on the kinetics of circulating CD34+ cells and WBC after chemotherapy and G-CSF mobilization.
Rossi G; Skert C; Morello E; Almici C; Arcaini L; Basilico C; Cavalli L; Botto B; Castelli A; Pica G; Ripamonti F; Salvi F; Carella AM; Gaidano G; Levis A; Nosari A; Russo D; Vitolo U
Hematol Oncol; 2015 Sep; 33(3):125-32. PubMed ID: 24890497
[TBL] [Abstract][Full Text] [Related]
16. Automated collection of peripheral blood stem cells with the COBE spectra for autotransplantation.
Heuft HG; Dubiel M; Kingreen D; Oertel J; De Reys S; Rick O; Serke S; Schwella N
Vox Sang; 2000; 79(2):94-9. PubMed ID: 11054047
[TBL] [Abstract][Full Text] [Related]
17. Patients' outcome after rescue plerixafor administration for autologous stem cell mobilization: a single-center retrospective analysis.
Spoerl S; Peter R; Wäscher D; Götze K; Verbeek M; Peschel C; Krackhardt AM
Transfusion; 2017 Jan; 57(1):115-121. PubMed ID: 27859332
[TBL] [Abstract][Full Text] [Related]
18. Factors determining pbsc mobilization efficiency and nonmobilization following ICE with or without rituximab (R-ICE) salvage therapy for refractory or relapsed lymphoma prior to autologous transplantation.
Xia W; Ma CK; Reid C; Bai L; Wong K; Kerridge I; Ward C; Greenwood M
J Clin Apher; 2014 Dec; 29(6):322-30. PubMed ID: 24944079
[TBL] [Abstract][Full Text] [Related]
19. Low-dose peripheral blood stem cell graft after high-dose chemotherapy - an evaluation of hematopoietic reconstitution.
Sauer S; Pavel P; Schmitt A; Cremer M; Kriegsmann M; Bruckner T; Jordan K; Wuchter P; Müller-Tidow C; Kriegsmann K
BMC Cancer; 2020 Apr; 20(1):353. PubMed ID: 32334570
[TBL] [Abstract][Full Text] [Related]
20. Improved Prediction of CD34+ Cell Yield before Peripheral Blood Hematopoietic Progenitor Cell Collection Using a Modified Target Value-Tailored Approach.
Sheppard D; Tay J; Palmer D; Xenocostas A; Doulaverakis C; Huebsch L; McDiarmid S; Tinmouth A; Mallick R; Martin L; Birch P; Hamelin L; Allan D; Bredeson C
Biol Blood Marrow Transplant; 2016 Apr; 22(4):763-767. PubMed ID: 26643030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
